/news/b/articles/archive/2017/12/11/skolkovo-cancer-drug-attracts-_2400_6-million-in-investment.aspxOncoTartis Inc., the U.S. daughter company of Skolkovo resident biomed startup OncoTartis , has raised $6 million in investment to develop its treatment for acute myeloid leukaemia. The acute myeloid leukaemia drug is being developed simultaneously7.x Production